AT374187B - Verfahren zur herstellung neuer 4-((3,4-dialkoxyphenyl)- alkyl)-2-imidazol idinon-derivaten - Google Patents
Verfahren zur herstellung neuer 4-((3,4-dialkoxyphenyl)- alkyl)-2-imidazol idinon-derivatenInfo
- Publication number
- AT374187B AT374187B AT0684179A AT684179A AT374187B AT 374187 B AT374187 B AT 374187B AT 0684179 A AT0684179 A AT 0684179A AT 684179 A AT684179 A AT 684179A AT 374187 B AT374187 B AT 374187B
- Authority
- AT
- Austria
- Prior art keywords
- idinone
- dialkoxyphenyl
- imidazole
- derivatives
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU78GO1429A HU179019B (en) | 1978-11-01 | 1978-11-01 | Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA684179A ATA684179A (de) | 1983-08-15 |
AT374187B true AT374187B (de) | 1984-03-26 |
Family
ID=10996879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0684179A AT374187B (de) | 1978-11-01 | 1979-10-19 | Verfahren zur herstellung neuer 4-((3,4-dialkoxyphenyl)- alkyl)-2-imidazol idinon-derivaten |
Country Status (10)
Country | Link |
---|---|
US (1) | US4308278A (de) |
AT (1) | AT374187B (de) |
CH (1) | CH642357A5 (de) |
DE (1) | DE2943877A1 (de) |
FR (1) | FR2440360A1 (de) |
GB (1) | GB2036010B (de) |
HU (1) | HU179019B (de) |
IT (1) | IT1162792B (de) |
NL (1) | NL7907914A (de) |
SU (1) | SU1003756A3 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
US5128358A (en) * | 1988-01-19 | 1992-07-07 | Pfizer Inc. | Aryl substituted nitrogen heterocyclic antidepressants |
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
US4971959A (en) * | 1987-04-14 | 1990-11-20 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
US5274002A (en) * | 1987-04-14 | 1993-12-28 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
WO1992007567A1 (en) * | 1990-11-06 | 1992-05-14 | Smithkline Beecham Corporation | Imidazolidinone compounds |
US5395935A (en) * | 1992-05-08 | 1995-03-07 | Pfizer Inc. | Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents |
GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
GB9326600D0 (en) * | 1993-12-22 | 1994-03-02 | Celltech Ltd | Chemical compounds |
US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
EP0799040B1 (de) * | 1994-12-13 | 2003-08-20 | Euroceltique S.A. | Dreifachsubstituierte thioxanthine |
CA2206287C (en) * | 1994-12-13 | 2001-03-20 | Mark Chasin | Aryl thioxanthines |
US6166041A (en) * | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US6075016A (en) * | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
US5864037A (en) | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
US5744473A (en) * | 1996-09-16 | 1998-04-28 | Euro-Celtique, S.A. | PDE IV inhibitors: "bis-compounds" |
US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
JP2001504457A (ja) * | 1996-11-01 | 2001-04-03 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化ホスホジエステラーゼ阻害剤化合物、組成物及びその使用法 |
US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
USRE37234E1 (en) * | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
EP1265861A2 (de) * | 2000-03-16 | 2002-12-18 | Inflazyme Pharmaceuticals, Ltd. | Benzylierte pde4-inhibitoren |
CN1946665B (zh) * | 2004-04-08 | 2011-06-15 | 惠氏公司 | 3-环戊氧基-4-甲氧基苯甲醛的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3892777A (en) * | 1968-05-01 | 1975-07-01 | Hoffmann La Roche | Substituted benzylethylenedicarbamates |
FR2081377A1 (en) * | 1969-12-18 | 1971-12-03 | Merck & Co Inc | L-alpha-hydrazino-beta-phenylpropionic acid compounds - decarboxylase inhibitors |
US3636039A (en) * | 1970-02-24 | 1972-01-18 | Hoffmann La Roche | Substituted benzylimidazolidinones |
BE787617A (fr) * | 1971-08-16 | 1973-02-16 | Bristol Myers Co | Imidazolines et procede pour les preparer |
-
1978
- 1978-11-01 HU HU78GO1429A patent/HU179019B/hu not_active IP Right Cessation
-
1979
- 1979-10-19 AT AT0684179A patent/AT374187B/de not_active IP Right Cessation
- 1979-10-23 GB GB7936680A patent/GB2036010B/en not_active Expired
- 1979-10-29 NL NL7907914A patent/NL7907914A/nl not_active Application Discontinuation
- 1979-10-30 FR FR7926837A patent/FR2440360A1/fr active Granted
- 1979-10-30 DE DE19792943877 patent/DE2943877A1/de not_active Withdrawn
- 1979-10-31 IT IT26949/79A patent/IT1162792B/it active
- 1979-10-31 CH CH975479A patent/CH642357A5/de not_active IP Right Cessation
- 1979-10-31 SU SU792832901A patent/SU1003756A3/ru active
- 1979-11-01 US US06/090,450 patent/US4308278A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NL7907914A (nl) | 1980-05-06 |
HU179019B (en) | 1982-08-28 |
ATA684179A (de) | 1983-08-15 |
SU1003756A3 (ru) | 1983-03-07 |
IT7926949A0 (it) | 1979-10-31 |
IT1162792B (it) | 1987-04-01 |
FR2440360B1 (de) | 1983-05-20 |
GB2036010A (en) | 1980-06-25 |
FR2440360A1 (fr) | 1980-05-30 |
GB2036010B (en) | 1982-12-01 |
DE2943877A1 (de) | 1980-06-04 |
US4308278A (en) | 1981-12-29 |
CH642357A5 (de) | 1984-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT374187B (de) | Verfahren zur herstellung neuer 4-((3,4-dialkoxyphenyl)- alkyl)-2-imidazol idinon-derivaten | |
ATA39879A (de) | Verfahren zur herstellung neuer 2-(2-methoxy-4- | |
AT371817B (de) | Verfahren zur herstellung neuer ergolinderivate | |
AT372094B (de) | Verfahren zur herstellung neuer corticoid-21halogen-17-alkylcarbonate | |
AT376220B (de) | Verfahren zur herstellung neuer 1,4-dihydropyridinderivate | |
AT367011B (de) | Verfahren zur herstellung des neuen 1(s), 4(r), | |
AT362777B (de) | Verfahren zur herstellung von 4-(6'-methoxy-2'naphthyl)-butan-2-on | |
AT374173B (de) | Verfahren zur herstellung neuer 2,6 -dialkoxybenzamide, ihrer salze und stereoisomeren | |
ATA296079A (de) | Verfahren zur herstellung des neuen 17alphaethinyl-1,3-dibenzoyloxy-7alpha-methyl-1,3,5(10)oestratrien-17beta-ols | |
AT366699B (de) | Verfahren zur herstellung von 3'', 4''-diacyltylosinderivaten | |
AT379144B (de) | Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate | |
AT373885B (de) | Verfahren zur herstellung von 1,2,3-thiadiazol -5-yl-harnstoffen | |
AT367773B (de) | Verfahren zur herstellung von 25,26-dihydroxycholesterin | |
AT355036B (de) | Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one | |
AT362389B (de) | Verfahren zur herstellung neuer nitrosoharn- stoff-derivate | |
AT361010B (de) | Verfahren zur herstellung des neuen 1,6-di-0- methansulfonyl-3,4-di-0-methyl-d-mannits | |
AT376683B (de) | Verfahren zur herstellung neuer 1-oxa-4-aza-2,6- disilacyclohexane | |
AT367758B (de) | Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten | |
AT356657B (de) | Verfahren zur herstellung von 2,6-methano-3- -benzazocinen | |
AT365606B (de) | Verfahren zur herstellung neuer 1,6-anhydro-beta- d-hexopyranosederivate | |
AT367417B (de) | Verfahren zur herstellung eines neuen 3,4dihydroxyzimtaldehydderivates | |
AT366377B (de) | Verfahren zur herstellung von neuen 1,1diphenylaethen-derivaten | |
ATA415383A (de) | Verfahren zur herstellung neuer 2-hydroxymethyl-3,4,5-trihydroxypiperidinderiva e | |
ATA428881A (de) | Verfahren zur herstellung von neuen 1,2,4triazolderivaten | |
ATA113580A (de) | Verfahren zur herstellung von 1,5-pentandiaminen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |